Neumorphism white abstract eye _edited.jpg

Newsroom

Discover PulseMedica in the news! Read company announcements, development progress, and more.

Featured in

Recent News Story

March 4, 2026

PulseMedica Wins health.tech Startup Competition in Basel

The recognition highlights PulseMedica’s momentum in developing a first-in-class platform to image, track, and treat eye floaters.

Learn More

PulseMedica in the News

Published by:

Alberta Innovates

Jan 11, 2024

AICE Validate Program Success Story

Alberta Innovates supports companies like PulseMedica as they develop technology to make our lives better.

Watch Video

Published by:

Ophthalmology Innovation Source

Feb 2, 2022

A Laser-Focused Business Model, with Nir Katchinskiy, PhD and Lahav Gil

The OIS podcast features leaders and drivers of ophthalmic innovation from around the world. In January 2022, PulseMedica’s CEO Nir Katchinskiy and Advisor Lahav Gil joined Dr. Ehsan Sadri MD FACS on the Ophthalmology Innovation Source (OIS) podcast.

Listen Now

Published by:

Optics.org

Apr 4, 2022

PulseMedica closes $2.6M seed round

Early-stage financing for Canadian startup developing ultrafast laser treatment of several eye diseases.

Read Article

Published by:

Startup TNT

Nov 19, 2021

PulseMedica, Winner of the TNT Investment Summit

A company that’s working on a revolutionary solution for patients suffering from major eye diseases took home the top prize in the Edmonton third of Startup TNT’s Investment Summit IV.

Read Article

Published by:

Taproot Edmonton

Mar 30, 2022

PulseMedica raises $2.6M as it prepares to launch laser treatment trial

PulseMedica has raised an oversubscribed $2.6-million seed round, which it largely plans to use to run its first clinical trial beginning in June. The University of Alberta spinoff company is working on a new way to treat patients with major eye diseases.

Read Article

Published by:

CBC Listen

Sep 10, 2021

Fixing Our Eyes

In September 2021's edition of Radio Active, CBC News' Liam Harop spoke with PulseMedica's co-founder and CEO, Nir Katchinskiy about the potential impact of the company's innovative laser treatment device.

Listen Now

5
Page 4